Tharun T. Oommen

Alwaye, KL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Conclusions in search of a confirmatory analysis: the evidence does not yet justify routine proton pump inhibitors after endoscopic variceal ligation.

Conclusions in search of a confirmatory analysis: the evidence does not yet justify routine proton pump inhibitors after endoscopic variceal ligation.

Journal: Gut

Published: April 16, 2026

Palliative Healthy Donor Stool Transplantation (pFMT) in Patients with End-Stage Alcohol-Related Cirrhosis and Severe Unstable Decompensations-A Cohort Study.

Palliative Healthy Donor Stool Transplantation (pFMT) in Patients with End-Stage Alcohol-Related Cirrhosis and Severe Unstable Decompensations-A Cohort Study.

Journal: Journal of clinical medicine

Published: March 04, 2026

A randomized controlled trial of L-taurine for fatigue in decompensated cirrhosis.

A randomized controlled trial of L-taurine for fatigue in decompensated cirrhosis.

Journal: Hepatology communications

Published: February 04, 2026

Mortality predictors, hepatic involvement patterns, and the steatotic liver paradox in 1,484 hospitalized Dengue patients.

Mortality predictors, hepatic involvement patterns, and the steatotic liver paradox in 1,484 hospitalized Dengue patients.

Journal: PloS one

Published: January 23, 2026

Novel Insights on Clinical Outcomes Using Integrated Shotgun Metagenomic Profiling of the Gut Microbiome, Resistome, and Host Immune-Inflammatory Response in Hospitalized Patients with Decompensated Cirrhosis.

Novel Insights on Clinical Outcomes Using Integrated Shotgun Metagenomic Profiling of the Gut Microbiome, Resistome, and Host Immune-Inflammatory Response in Hospitalized Patients with Decompensated Cirrhosis.

Journal: Pathogens (Basel, Switzerland)

Published: January 15, 2026

Analysis of 386 alternative medicinal products implicated in liver injury reveal clinically relevant associations with potentially hepatotoxic botanicals, pharmaceutical adulteration, heavy metal contamination, and undisclosed animal content.

Analysis of 386 alternative medicinal products implicated in liver injury reveal clinically relevant associations with potentially hepatotoxic botanicals, pharmaceutical adulteration, heavy metal contamination, and undisclosed animal content.

Journal: Frontiers in gastroenterology (Lausanne, Switzerland)

Published: January 10, 2026

A cluster analysis of 466 patients demonstrates that glutathione supplementation could preferentially benefit advanced unstable cirrhosis phenotype rather than stable cirrhosis.

A cluster analysis of 466 patients demonstrates that glutathione supplementation could preferentially benefit advanced unstable cirrhosis phenotype rather than stable cirrhosis.

Journal: Frontiers in pharmacology

Published: December 14, 2025

Stereotactic body radiotherapy and other locoregional therapies for hepatocellular carcinoma in patients with cirrhosis: real-world treatment allocation, BCLC-stratified outcomes, and prognostic determinants.

Stereotactic body radiotherapy and other locoregional therapies for hepatocellular carcinoma in patients with cirrhosis: real-world treatment allocation, BCLC-stratified outcomes, and prognostic determinants.

Journal: Discover oncology

Published: December 05, 2025

Addressing the Elephant in the Room: Herbal Liver Injury is More Severe and Catastrophic Than Liver Injury From Conventional Drugs.

Addressing the Elephant in the Room: Herbal Liver Injury is More Severe and Catastrophic Than Liver Injury From Conventional Drugs.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: December 03, 2025

Letter to the Editor: Placebo drift, dose heterogeneity, and the winner's curse-Re-evaluating the hierarchy of MASH therapeutics.

Letter to the Editor: Placebo drift, dose heterogeneity, and the winner's curse-Re-evaluating the hierarchy of MASH therapeutics.

Journal: Hepatology (Baltimore, Md.)

Published: November 24, 2025

Unique Clinically Relevant Prognostic Indicators After TIPS Placement in Cirrhosis Patients with Pre-Existing Kidney Disease.

Unique Clinically Relevant Prognostic Indicators After TIPS Placement in Cirrhosis Patients with Pre-Existing Kidney Disease.

Journal: Journal of clinical medicine

Published: November 24, 2025

"Facts are Stubborn Things, but Statistics are Pliable" -Concerns Regarding Meta-Analysis of Granulocyte Colony-Stimulating Factor Therapy in Severe Alcohol-Associated Hepatitis.

"Facts are Stubborn Things, but Statistics are Pliable" -Concerns Regarding Meta-Analysis of Granulocyte Colony-Stimulating Factor Therapy in Severe Alcohol-Associated Hepatitis.

Journal: Journal of clinical and experimental hepatology

Published: November 20, 2025

Showing 1-12 of 18

Last Updated: 09/26/2026